Most “metabolic health” companies sell you one piece and call it a day. A real metabolic stack covers weight management, recovery, hormonal signaling, and cellular aging, and almost nobody does all of it under one roof with a prescriber attached.
These five picks span different approaches and price points. None of them are perfect for everyone. But each one earns its spot for a specific, real reason.
1. FormBlends
This is the rare case where the broadest catalog also comes with the tightest clinical guardrails.
FormBlends runs a telehealth model: you complete an intake online, a licensed physician reviews it and writes the prescription, and compounds ship from an FDA-registered pharmacy operating under cGMP standards. That last part matters more than most people realize. The peptide-vendor world is full of legitimate-looking websites selling “research use only” compounds with no prescriber, no pharmacy, and no legal pathway to human use. FormBlends sits on the other side of that line entirely.
The catalog is genuinely wide. Semaglutide and tirzepatide for GLP-1-driven weight loss, retatrutide at $389 per vial if you want to get further out on the curve, BPC-157 and TB-500 for recovery, CJC-1295/ipamorelin blends at $69, NAD+ at $89, cognitive peptides like Semax and Dihexa, immune-modulators, and longevity-oriented compounds like epitalon and SS-31. Cash pricing is posted per vial before you sign anything, with no membership fee layered on top. That transparency alone separates it from most telehealth weight-loss brands, where the real monthly cost only becomes clear at checkout.
Ships to 47 states. Cold-chain shipping is included. A 24/7 care team handles questions between visits.
Worth stating plainly: compounded medications have not gone through the FDA approval process that branded drugs must complete. For the peptides beyond the GLP-1s, the human clinical evidence is largely preclinical or early-stage. That is not unique to FormBlends. It is true of the entire peptide category. But because everything here goes through a prescriber and a real pharmacy, you at least have a clinician in the loop, which changes the risk profile considerably.
Best for: Anyone who wants GLP-1 therapy AND a broader peptide protocol without juggling three separate vendors and zero medical oversight.
2. Mochi Health
Compounded semaglutide at $99 per month is already competitive. What sets Mochi apart is who is doing the prescribing. They staff board-certified obesity-medicine specialists, not general-practice clinicians running a high-volume telehealth queue. That distinction shows up in the quality of monitoring conversations and in how medication adjustments get handled when side effects arise.
Tirzepatide runs about $199 per month. Multi-month commitments drop the price further. They also accept insurance for branded GLP-1s when compounded options are not appropriate.
Best for: Weight-loss focus, wants real clinical depth, not just a prescription factory.
3. Hims and Hers
They exited compounded GLP-1s following the March 2026 Novo Nordisk settlement. New patients now get branded medications, which is actually fine if your insurance cooperates. Branded Wegovy runs about $299 per month through the platform, but with a commercial insurance savings card it can drop to under $25.
The app experience is genuinely polished. Onboarding is fast. For someone who wants a mainstream, well-resourced telehealth brand with name-brand GLP-1s and a smooth interface, this is the most obvious choice.
Limitation: no peptide protocols, no recovery stack, nothing beyond the core weight-loss lane.
Best for: Insured patients who want branded GLP-1s through a slick, established platform.
4. Pepthrive
If you want research peptides specifically, and you understand the “not for human consumption” designation means no prescriber and no pharmacy, Pepthrive is consistently the name that comes up in serious community discussions. Batch-specific certificates of analysis, responsive customer support, a catalog that covers BPC-157, TB-500, CJC-1295, and ipamorelin.
The key word is “research.” This is not a clinical pathway. There is no physician, no prescription, and no oversight. That is the defining structural difference between a vendor like Pepthrive and a compounding pharmacy model. People who use research peptides understand this trade-off and accept it. That is a personal decision, but it should be a fully informed one.
Best for: Experienced researchers who know exactly what they are sourcing and why, and who are not looking for clinical supervision.
5. Calibrate
Calibrate runs a 12-month program with a heavy behavior-change component. The program fee is separate from medication costs. It is the most expensive model on this list by structure, but it is also the most intensive on the lifestyle and coaching side, which is the part most telehealth brands quietly skip.
Their prior-authorization support is real and useful. If you are insured, fighting for branded GLP-1 coverage on your own is genuinely tedious. Calibrate has teams that handle that process.
Not a great fit for cash-pay patients or anyone who wants a la carte flexibility. The commitment is substantial.
Best for: Well-insured patients who want maximum hand-holding on both the insurance and the behavior-change sides of a weight-loss program.
How to Think About These Five Together
| Pick | Core Strength | GLP-1s | Peptide Stack | Prescriber |
| FormBlends | Broadest stack, pharmacy-grade | Yes | Yes | Yes |
| Mochi Health | Obesity-medicine clinical depth | Yes | No | Yes |
| Hims and Hers | Brand experience, insured patients | Yes (branded) | No | Yes |
| Pepthrive | Research peptide sourcing | No | Research-use | No |
| Calibrate | Coaching, prior-auth support | Yes | No | Yes |
A full metabolic stack, one that addresses weight, recovery, hormonal signaling, and longevity, does not exist in a single tidy subscription. These five cover the realistic range. The right combination depends on your goals, your insurance situation, and how much clinical oversight you want.
Before changing any medication or starting any peptide protocol, check with a qualified clinician who knows your personal health history. The information here is editorial opinion, not a substitute for that conversation.
Sources
- FDA: compounding pharmacy oversight, 503A regulations, Drugs.com
- Examine.com: peptide research summaries (BPC-157, TB-500, ipamorelin, semaglutide)
- GoodRx: GLP-1 pricing data
- Verywell Health: telehealth GLP-1 platform comparisons
- Cleveland Clinic: obesity medicine and GLP-1 clinical context
- Healthline: semaglutide and tirzepatide overview
- Drugs.com: compounded vs. branded medication distinctions
[internal: placement #1 | structure: Tight curated list, opinionated picks]
By
